Skip to Content
Jump to the top of the page

William Blair Thinking

  • Business Owners Forum: Transition to Liquidity: Tax, Risk, and Opportunity for Founders and Owners

    Chris Brathwaite, partner and director of Pre-Liquidity Planning, and Andrew Hansen with our Founder-Owned Business Advisory team lead a discussion designed for business owners and founders who have recently completed—or are preparing for—a major liquidity event.

    Read more
  • Leveraged Loan Market Bounces Back From a Spooky Second Quarter

    The leveraged finance market has brought a rollercoaster of emotions in 2025.

    Read more
  • Agricultural Irrigation's Next Chapter: Evolving Irrigation Technologies

    Learn how advanced precision irrigation is addressing global water shortages, driving crop production, and creating compelling investment opportunities.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Matt Zimmer Discusses Deal Outlook, PE Strategy, Secondaries on Bloomberg TV

    Global Head of Investment Banking Matt Zimmer recently appeared on Bloomberg TV’s “Open Interest” program.

    Read more
  • William Blair Initiates Coverage of Five Companies in the Rare Earth Industry

    William Blair initiated research coverage of USA Rare Earth, Inc. (USAR $28.54), United States Antimony Corporation (UAMY $12.56), American Resources Corporation (AREC $4.25), NioCorp Developments Ltd. (NB $8.30), and Royalty Management Holding Corporation (RMCO $2.96).

    Read more
  • Climb Bio, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Climb Bio, Inc. (CLYM $1.88), which is developing high-impact medicines for patients living with autoimmune diseases, with the CD19 antibody budoprutug as its lead program.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures